Dec 18, 2023|1 min readEngineering other cells of the immune systemChimeric antigen receptor engineering is now possible for immune cells other than T cells, including macrophages and invariant natural killer T cells.
Cancer ResearchMar 01, 2021|3 min readBy Mel J. YeatesFDA approves PepaxtoOncopeptides’ Pepaxto has been approved for patients with triple-class refractory multiple myeloma